![Immunohistochemistry predictive markers for primary colorectal cancer tumors: where are we and where are we going? | Semantic Scholar Immunohistochemistry predictive markers for primary colorectal cancer tumors: where are we and where are we going? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ddf6fa7addf30b0810d829bc350a3c7e0ef4fb98/3-Table1-1.png)
Immunohistochemistry predictive markers for primary colorectal cancer tumors: where are we and where are we going? | Semantic Scholar
![Biology | Free Full-Text | Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation Biology | Free Full-Text | Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation](https://www.mdpi.com/biology/biology-10-00874/article_deploy/html/images/biology-10-00874-g001.png)
Biology | Free Full-Text | Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation
![Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells - ScienceDirect Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535947620336628-gr1.jpg)
Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells - ScienceDirect
![Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review](https://www.frontiersin.org/files/Articles/523977/fonc-10-01742-HTML/image_m/fonc-10-01742-t003.jpg)
Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
![Evaluation of Diagnostic Utility of Immunohistochemistry Markers of TROP-2 and HBME-1 in the Diagnosis of Thyroid Carcinoma in: European Thyroid Journal Volume 8 Issue 1 (2019) Evaluation of Diagnostic Utility of Immunohistochemistry Markers of TROP-2 and HBME-1 in the Diagnosis of Thyroid Carcinoma in: European Thyroid Journal Volume 8 Issue 1 (2019)](https://etj.bioscientifica.com/view/journals/etj/8/1/images/ETJ494430_T01_B.jpeg)
Evaluation of Diagnostic Utility of Immunohistochemistry Markers of TROP-2 and HBME-1 in the Diagnosis of Thyroid Carcinoma in: European Thyroid Journal Volume 8 Issue 1 (2019)
![An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09169-0/MediaObjects/12885_2022_9169_Fig1_HTML.png)
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
![Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia‑inducible factor‑1α expression is involved in prostate epithelial malignancy Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia‑inducible factor‑1α expression is involved in prostate epithelial malignancy](https://www.spandidos-publications.com/article_images/ol/8/3/OL-08-03-0985-g01.jpg)